Author

Anthony M. Doherty

Edinburgh Cancer ResearchORCID 0000-0003-3519-4178Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Adrian P. BrackeniD· 1 shared Christoper Ott· 1 shared Christopher R. VakociD· 1 shared Craig MongeriD· 1 shared Eimear LaganiD· 1 shared Gerard L. BrieniD· 1 shared Giorgio OlivieroiD· 1 shared Junwei ShiiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adrian P. BrackenORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintJan 27, 2026

SS18-SSX co-opts P300 to sustain oncogenic transcription independent of SWI/SNF activity

Anthony M. Doherty, Eimear Lagan, Richard J. R. Elliott…·Gerard L. Brien

This study shows SS18-SSX sustains oncogenic transcription without needing SWI/SNF activity, identifies P300 as a critical co-factor, and demonstrates targeting P300 or SWI/SNF as therapeutic strategies.

1 citation

humanDNA methylation

𝕏 PostBluesky